We are live on ! Find out more
UPH

UpHealth, Inc.

Delisted

UPH was delisted on the 11th of December, 2023.

32 hedge funds and large institutions have $6.48M invested in UpHealth, Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $5.33M → $6.48M (+$1.15M)

10% more funds holding

Funds holding: 2932 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.58% less ownership

Funds ownership: 27.46%23.88% (-3.6%)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
5
Reduced
6
Closed
Calls
$80K
Puts
Net Calls
+$80K
Net Calls Change
+$17K

UPH Hedge Fund Activity: Q2 2023 in Review

32 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in UpHealth, Inc. (UPH) for Q2 2023, worth a combined $6.48M — up 22% from $5.33M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new UPH positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Cresset Asset Management, opening a new position worth an estimated $65.5K. The largest seller was Armistice Capital, cutting an estimated $291K.

  • 32 institutional investors held UpHealth, Inc. (UPH) as of Q2 2023, up from 29 in Q1 2023.
  • Funds reported $6.48M of UpHealth, Inc. stock for Q2 2023, up 22% quarter-over-quarter.
  • 3 funds opened new UpHealth, Inc. positions in Q2 2023 and 0 closed out, a net change of +3 holders.
  • The largest UpHealth, Inc. buyer in Q2 2023 was Cresset Asset Management, an estimated $65.5K added.
  • The largest UpHealth, Inc. seller in Q2 2023 was Armistice Capital, an estimated $291K sold.

Based on aggregated 13F filings for Q2 2023.